MedPath

The Effect of Virtual Reality on Pulmonary Recovery and Mobility in Patients With Blunt Chest Trauma

Not Applicable
Terminated
Conditions
Blunt Chest Trauma
Interventions
Device: Virtual Reality
Registration Number
NCT05194176
Lead Sponsor
Radboud University Medical Center
Brief Summary

Blunt chest trauma comprises over 10% of all trauma patients presenting to emergency departments worldwide and is the most frequent injury in polytrauma patients. It is associated with high risk (\>10%) of pulmonary complications such as pneumonia. Pillars of treatment are adequate pain relief, respiratory function exercises and rapid mobilisation through physiotherapy. Inadequate pain control can result in restricted ventilatory function and in reduced mobility, both resulting in a higher risk of particularly pulmonary complications. Virtual Reality (VR) might be an easy to use, individualized, and harmless technique that can facilitate pulmonary recovery and aid in the prevention of complications through reducing pain and promoting exercising. The investigators hypothesize that VR improves respiratory function and mobilisation in the post-acute phase of blunt chest trauma by distracting patients from pain and stress, and by stimulating pulmonary and physical exercise.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Admitted to the trauma ward with sustained blunt chest trauma
  • Age≥16
  • Patient is willing and able to comply with the study protocol
Exclusion Criteria
  • Neurotrauma with GCS ≤13
  • History of dementia, seizures, epilepsy
  • Severe hearing/visual impairment not corrected
  • Head wounds or damaged skin with which comfortable and hygienic use is not possible.
  • Stay at intensive care unit (ICU) during current hospital admission.
  • Erect position in bed not possible/allowed.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Virtual RealityVirtual RealityThe intervention group will be instructed to perform the respiratory exercises using the VR-intervention 8 times daily for 10 minutes and to extend these exercises 2 times daily with (sitting) physical exercises for an additional 10 minutes. The respiratory exercises in VR are comparable to the exercises in usual care but performed in a virtual environment and without incentive spirometry. The physical exercises consist of several games through which patients are challenged to reach out to objects while engaging their core. Patients are allowed to continue these exercises or play some relaxation games for up to 30 minutes per session in total. The exercises will be performed once daily under supervision of a physiotherapist. The other sessions will be unsupervised.
Primary Outcome Measures
NameTimeMethod
Inspiration volume, mean change from baselineFrom baseline to end of treatment at day 5.

Mean change from baseline in inspiration volume in ml, measured with an incentive spirometer (Voldyne)

Inspiration volume, repeated measures over 5 daysTwice daily from enrollment to day 5 of treatment

change in mean daily inspiration volume in mL, measured with an incentive spirometer (Voldyne)

Secondary Outcome Measures
NameTimeMethod
Time spent sitting or standing, mean change from baselineContinuously from enrollment to end of treatment at day 5.

Measured continuously using a wearable activity monitor, calculated as percentage of time spent sitting or standing.

Length of hospital stayAt end of follow-up, 30 days after discharge

Length of hospital stay in days

Pulmonary complications during admissionAt end of follow-up, 30 days after discharge

Number and type of pulmonary complications during admission

Transfers to ICUAt end of follow-up, 30 days after discharge

Participant transferred to ICU during admission yes/no?

Readmission within 30 daysAt end of follow-up, 30 days after discharge

Participant readmitted within 30 days, yes/no

Pain score during breathing exercise using Visual Analogue Score (VAS)Daily from baseline to end of treatment at day 5.

VAS pain score during breathing exercise (0-100mm). A higher score means a worse outcome.

Powerless in Daily living questionnaireDaily from baseline to end of treatment at day 5.

Powerless in Daily living questionnaire (0-21), a higher score means a worse outcome.

Quality of Recovery-15 questionnaireDaily from baseline to end of treatment at day 5.

Quality of Recovery-15 questionnaire (0-150), a higher score means a better outcome.

Trial Locations

Locations (1)

Radboud university medical center

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath